Registration for the 10th Annual Dinner & Legislative Fly-In will open in early 2019!
2019 Agenda | Tuesday, May 21, 2019
Concurrent Committee Meetings
Open to ARM Members Only
Regulatory Committee Meeting (Algonquin Room)
Reimbursement Committee Meeting (Pearl Room)
Government Relations Committee Meeting (Algonquin Room)
Patient Engagement Committee Meeting (Pearl Room)
Policy Lunch Briefing with NIH Director Dr. Francis Collins
National Institutes of Health (NIH) Director, Dr. Francis Collins, will deliver a keynote address offering his outlook for cell and gene therapy. The briefing will address NIH’s important scientific and policy work in this area including planned changes in the RAC review for gene therapy trials and NIH support of research and development of gene therapies. The address will also allow time for audience members to ask questions during a dedicated Q&A session.
ARM State of the Industry Mid-Year Update
ARM CEO, Janet Lambert, will provide a mid-year update on the industry’s legislative and clinical progress to date as well as a forecast of anticipated achievements and challenges. The address will include insights into key sector trends and metrics, and a policy overview in advance of the following day’s Annual Legislative Fly-In.
Panel: Externally-Led Patient-Focused Drug Development Meetings
This multi-stakeholder discussion will discuss how these meetings are organized and the systematic approach they provide to ensure that patient’s experiences, perspectives, needs and priorities are meaningfully incorporated into drug development and evaluation.
After a short afternoon break, join us again for ARM’s 10th Annual Dinner. The Annual Dinner is one of ARM’s premier events celebrating major accomplishments over the past year in the regenerative medicine and advanced therapies field. This intimate dinner recognizes the key corporate, scientific and policy leaders in our sector – including members of Congress, patient advocates, disease-foundation executives and other industry champions.
Janet Lambert, CEO, Alliance for Regenerative Medicine
Cara O’Neill, M.D., Scientific Director & Executive Vice President, Cure Sanfilippo Foundation
Kristin Smedley, President, Curing Retinal Blindness Foundation
Wednesday, May 22, 2019
Each participant will be assigned to a group based on state/districts and will meet with key members of Congress and Administration officials to describe the immense near-term potential of advanced therapies and the need for legislation that supports the development of life saving treatments.
Open to ARM Members Only, Registration Required
Breakfast & Legislative Issues Briefing (Harbor Room)